SCHEMBL21394567

SCHEMBL21394567

CCc1cc(Cl)cc(C(=O)OC)c1NS(=O)(=O)C1CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX1 Q96LB2 5/20 0.44
SLC6A3 Q01959 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ABL1 P00519 1/20 0.38
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
CTPS1 P17812 2/20 0.37
FLT1 P17948 1/20 0.37
FLT4 P35916 1/20 0.37
KDR P35968 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
TLR4 O00206 1/20 0.36
EPHX2 P34913 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
TSPO P30536 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21384579 0.84 MRGPRX1 (0.41) MRGPRX1SLC6A3MEN1KMT2AABL1
SCHEMBL21381359 0.83 MRGPRX1 (0.43) MRGPRX1SLC6A3ABL1ALDH1A1MAPT
SCHEMBL21384614 0.77 MRGPRX1 (0.57) MRGPRX1SLC6A3ABL1TLR4TSPO
SCHEMBL30810287 0.73 KDM4E (0.45) SLC6A3MEN1KMT2AABL1ALDH1A1
SCHEMBL30810266 0.71 HPGD (0.50) SLC6A3MEN1KMT2AABL1HCRTR1
SCHEMBL21384541 0.70 ABL1 (0.48) MRGPRX1SLC6A3MEN1KMT2AABL1
SCHEMBL21384561 0.70 ACLY (0.48) MRGPRX1CTPS1ALDH1A1KDM4E
SCHEMBL10174510 0.70 ABL1 (0.57) SLC6A3MEN1KMT2AABL1HCRTR1
SCHEMBL10487662 0.70 ABL1 (0.62) SLC6A3MEN1KMT2AABL1HCRTR1
SCHEMBL21384566 0.69 MRGPRX1 (0.42) MRGPRX1ALDH1A1TSHRTLR4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019179436-A1 ACID AMIDE COMPOUND AND USE THEREOF IN TREATMENT OF CANCERS 成都海创药业有限公司 2019-09-26 WO disclosed